Comparison of outcomes for fixed and weight-based four-factor prothrombin complex concentrate dosing regimens.

Area of Science:

• Hematology
• Pharmacology
• Clinical Medicine

Background:

• Fixed dose regimens for four-factor prothrombin complex concentrate (4F-PCC) are increasingly used, but their efficacy compared to weight-based dosing requires further investigation.
• Uncertainty exists regarding the 'one size fits all' approach in 4F-PCC administration for various bleeding types and anticoagulants.

Purpose of the Study:

• To compare hemostasis achievement between fixed dose and weight-based dose 4F-PCC regimens.
• To evaluate differences in time to administration and in-hospital mortality between the two dosing strategies.

Main Methods:

• Retrospective cohort study including adult patients receiving 4F-PCC for major bleeding on warfarin or factor-Xa inhibitors.
• Comparison of fixed dose (treatment) versus weight-based dose (comparator) 4F-PCC regimens.
• Exclusion criteria included non-urgent procedures, unknown hemorrhage source, non-anticoagulated patients, hepatic failure, dabigatran use, or heparin allergy.

Main Results:

• No statistically significant difference in hemostasis achievement between fixed dose (45%) and weight-based dose (46%) groups (p=0.872).
• Fixed dose 4F-PCC administration was significantly faster (32 min vs 46 min, p=0.031).
• In-hospital mortality rates were similar between groups (29% vs 29%, p=0.968).

Conclusions:

• Fixed dose 4F-PCC regimens demonstrate comparable hemostasis outcomes to weight-based regimens.
• Fixed dosing facilitates a quicker administration time, a crucial factor in managing major bleeding events.